A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current...

16
1 A Platform for the Discovery of New Macrolide Antibiotics Ian B. Seiple, Ziyang Zhang, Pavol Jakubec, Audrey Langlois-Mercier, Peter M. Wright, Daniel T. Hog, Kazuo Yabu, Senkara Rao Allu, Takehiro Fukuzaki, Peter N. Carlsen, Yoshiaki Kitamura, Xiang Zhou, Matthew L. Condakes,Filip T. Szczypiński, William D. Green & Andrew G. Myers Nature, 2016, 533, Page 338 Presented by Alexander Chatterley 15 th of October 2016 Alex Chatterley @ Wipf Group Page 1 of 16 11/12/2016

Transcript of A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current...

Page 1: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

1

A Platform for the Discovery of New Macrolide Antibiotics

Ian B. Seiple, Ziyang Zhang, Pavol Jakubec, Audrey Langlois-Mercier, Peter M. Wright, Daniel T. Hog, Kazuo Yabu, Senkara Rao Allu, Takehiro Fukuzaki, Peter N. Carlsen, Yoshiaki Kitamura, Xiang Zhou, Matthew L. Condakes,Filip T. Szczypiński,

William D. Green & Andrew G. Myers

Nature, 2016, 533, Page 338

Presented by Alexander Chatterley

15th of October 2016

Alex Chatterley @ Wipf Group Page 1 of 16 11/12/2016

Page 2: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

2

The Myers Group

Andrew Myers graduated from MIT 1981 with Bachelors of science.Graduate student and a brief post doc with E. J. Corey. Beganindependent career at Caltech (1986) then moved to Harvard in1998.

Comprised of 17 members (6grad students/8 post docs/3staff).

Research focuses includesynthesis of complex naturalantibiotics and thedevelopment of methodologyto aid in this.

Alex Chatterley @ Wipf Group Page 2 of 16 11/12/2016

Page 3: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

3

AntibioticsAntibiotics are one of the major corner stones of modern medicine.

Early reports of using mould as a poultice in pre-BC times totreat open wounds by applying moulds.

Use became more refined throughout history, particularly in thelate renaissance through to early industrial. For example the useof mould by apothecaries in England to treat injuries.

First anti-biotic isolated by British biologist Sir Andrew Flemingin 1928, arguably began the modern anti-bacterial era.

First chemical synthesis of penicillin in 1957 by Dr EdwardSheehan (supervisor to E. J. Corey).

Alex Chatterley @ Wipf Group Page 3 of 16 11/12/2016

Page 4: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

4

First synthesis of Pencillin

Alex Chatterley @ Wipf Group Page 4 of 16 11/12/2016

Page 5: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

5

Antibacterial Apocalypse

Antibiotic resistance is rapidly becoming a global health concern.

Over use of antibiotics in people and animals has causedmultiple strains of drug resistance bacteria to evolve.

No new class of antibiotics have been discovered in the 1980’s.

Antibiotic research while crucial, is not attractive to the privatesector due to the business model.

Alex Chatterley @ Wipf Group Page 5 of 16 11/12/2016

Page 6: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

6

Classes of antibiotics

There are several classes of antibiotics:

Penicillin'sAminoglycosidesCarbapenemsCephalosporin'sFluoroquinolonesSulphonamides

Marcolides

Alex Chatterley @ Wipf Group Page 6 of 16 11/12/2016

Page 7: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

7

Macrolide Antibiotics

Antibiot. Chemother. 1952, 2, 281.; Antimicrob. Agents Chemother. 1991, 35,2016.

Erythromycin, one of the earliest macrolides was isolated fromPhilippine soil samples in 1949.

Characterised by their large macrocyclic ring structure, Usually14, 15 or 16 membered.

Active against Gram-positive and to limited Gram-negativebacteria.

Binds reversibly to the P site on the 50S subunit of the bacterialribosome. This inhibits protein synthesis resulting in bacterialcell death.

Alex Chatterley @ Wipf Group Page 7 of 16 11/12/2016

Page 8: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

8

Macrolide synthesis

J. Am. Chem. Soc. 1981, 103, 3210, 3213 and 3215; J. Am. Chem. Soc. 1978, 100, 4618 and 4620; J. Am. Chem. Soc 1979, 101, 7131.

First total synthesis of Erythromycin A was completed by Woodward in1981.

0.089% total yield, 52 steps total. 48 students worked on it.

Total synthesis of Erythronolide A and Bcarried out by Corey in 1978/9.

Again, these were very complex synthesis,involving multiple students (including K.C.Nicolaou).

Alex Chatterley @ Wipf Group Page 8 of 16 11/12/2016

Page 9: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

9

This Paper

Meyers group embarked on a quest to synthesise a library ofmacrolides as a platform for the discovery of new antibiotics.

They divided this approach into three classes:

Alex Chatterley @ Wipf Group Page 9 of 16 11/12/2016

Page 10: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

10

14-Membered Azaketolides 1

Alex Chatterley @ Wipf Group Page 10 of 16 11/12/2016

Page 11: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

11

14-Membered Azaketolides 2

Alex Chatterley @ Wipf Group Page 11 of 16 11/12/2016

Page 12: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

12

15-Membered Azaketolides

Alex Chatterley @ Wipf Group Page 12 of 16 11/12/2016

Page 13: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

13

14 Membered Ketolides

Alex Chatterley @ Wipf Group Page 13 of 16 11/12/2016

Page 14: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

14

Library construction

Alex Chatterley @ Wipf Group Page 14 of 16 11/12/2016

Page 15: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

15

Microbiological testing

Screened 305 compounds against a panel of pathogens comprising of Gram+ and Gram – stains. 83% of the candidates showed a MIC of less than 4μg ml-1 against WT S.

pneumoniae.

Most promising candidates were screened against an expanded panel thathad developed various antibacterial resistance strategies. FSM-100573 and 100563 showed were more active than any current

clinical macrolide against mutated S. pneumoniae. and Pseudomonasaeruginosa.

Alex Chatterley @ Wipf Group Page 15 of 16 11/12/2016

Page 16: A Platform for the Discovery of New Macrolide Antibioticsccc.chem.pitt.edu/wipf/Current Literature/AlexC_4.pdf · 1 A Platform for the Discovery of New Macrolide Antibiotics Ian B.

16

Conclusions

In conclusion the Meyers group have made several contributions with thispublication:

Designed and executed several efficient and highly convergentroutes to three macrolide skeletons.

Further functionalised and furnished these skeletons to generate asynthetic library of 300+ macrolides.

Demonstrated that these candidates represent possible avenuesto new antimicrobial agents in the war against drug resistantbacteria.

Alex Chatterley @ Wipf Group Page 16 of 16 11/12/2016